M. Iregui, S. Ward, G. Sherman, V. J. Fraser, and M. H. Kollef, Clinical Importance of Delays in the Initiation of Appropriate Antibiotic Treatment for Ventilator-Associated Pneumonia, Chest. juill, vol.122, issue.1, pp.262-270, 2002.

E. L. Kuti, A. A. Patel, and C. I. Coleman, Impact of inappropriate antibiotic therapy on mortality in patients with ventilator-associated pneumonia and blood stream infection: A meta-analysis, J Crit Care. mars, vol.23, issue.1, pp.91-100, 2008.

K. C. Claeys, E. J. Zasowski, T. D. Trinh, A. M. Lagnf, S. L. Davis et al., Antimicrobial Stewardship Opportunities in Critically Ill Patients with Gram-Negative Lower Respiratory Tract Infections: A Multicenter Cross-Sectional Analysis, Infect Dis Ther. mars, vol.7, issue.1, pp.135-181, 2018.

K. K. Perez, R. J. Olsen, W. L. Musick, P. L. Cernoch, J. R. Davis et al., Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia, J Infect. sept, vol.69, issue.3, pp.216-241, 2014.

, OMS | Premier rapport de l'OMS sur la résistance aux antibiotiques: une menace grave d'ampleur mondiale

D. Sur,

, EAAD EARS-Net summary

J. Carlet, C. Rambaud, and C. Pulcini, Save Antibiotics: a call for action of the World Alliance Against Antibiotic Resistance (WAAAR), vol.28, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01808828

R. A. Smith, M. 'ikanatha, N. M. Read, and A. F. , Antibiotic Resistance: A Primer and Call to Action, Health Commun. mars, vol.30, issue.3, pp.309-323, 2015.

D. Marchaim, T. Chopra, A. Bhargava, C. Bogan, S. Dhar et al., Recent Exposure to Antimicrobials and Carbapenem-Resistant Enterobacteriaceae: The Role of Antimicrobial Stewardship, Infect Control Hosp Epidemiol. août, vol.33, issue.8, pp.817-847, 2012.

, Organization WH. Antimicrobial Resistance: Global Report on Surveillance. Geneva: World Health Organization, vol.232, 2014.

E. Papadomichelakis, F. Kontopidou, A. Antoniadou, G. Poulakou, E. Koratzanis et al., Screening for resistant gram-negative microorganisms to guide empiric therapy of subsequent infection, Intensive Care Med. déc, vol.34, issue.12, pp.2169-75, 2008.

H. Baba, G. R. Nimmo, A. M. Allworth, R. J. Boots, Y. Hayashi et al., The role of surveillance cultures in the prediction of susceptibility patterns of Gram-negative bacilli in the intensive care unit, Eur J Clin Microbiol Infect Dis. juin, vol.30, issue.6, pp.739-783, 2011.

P. Depuydt, D. Benoit, D. Vogelaers, G. Claeys, G. Verschraegen et al., Outcome in bacteremia associated with nosocomial pneumonia and the impact of pathogen prediction by tracheal surveillance cultures, Intensive Care Med, vol.32, issue.11, pp.1773-81, 2006.

S. Gómez-zorrilla, M. Camoez, F. Tubau, R. Cañizares, E. Periche et al., Prospective Observational Study of Prior Rectal Colonization Status as a Predictor for Subsequent Development of Pseudomonas aeruginosa Clinical Infections, Antimicrob Agents Chemother. sept, vol.59, issue.9, pp.5213-5222, 2015.

T. Tängdén, O. Cars, Å. Melhus, and E. Löwdin, Foreign Travel Is a Major Risk Factor for Colonization with Escherichia coli Producing CTX-M-Type Extended-Spectrum ?-Lactamases: a Prospective Study with Swedish Volunteers, Antimicrob Agents Chemother. sept, vol.54, issue.9, pp.3564-3572, 2010.

M. Agarwal, S. Shiau, and E. L. Larson, Repeat gram-negative hospital-acquired infections and antibiotic susceptibility: A systematic review, J Infect Public Health. juill, vol.11, issue.4, pp.455-62, 2018.

. Société-française-d'anesthésie and . Et, Antibiothérapie probabiliste des états septiques graves. Ann Fr D'Anesthésie Réanimation, vol.23, pp.1020-1026, 2004.

. Sfar2014 and . Pdf,

. Sfar2017 and . Pdf,

, Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcareassociated Pneumonia, Am J Respir Crit Care Med. 15 févr, vol.171, issue.4, pp.388-416, 2005.

A. C. Kalil, M. L. Metersky, M. Klompas, J. Muscedere, D. A. Sweeney et al., Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the, Clin Infect Dis. 1 sept, vol.63, issue.5, pp.61-111, 2016.

A. Torres, M. S. Niederman, J. Chastre, S. Ewig, P. Fernandez-vandellos et al., International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilatorassociated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilatorassociated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT), Eur Respir J. sept, vol.50, issue.3, p.1700582, 2017.

I. Martin-loeches, A. H. Rodriguez, and A. Torres, New guidelines for hospital-acquired pneumonia/ventilatorassociated pneumonia: USA vs, Europe. Curr Opin Crit Care. oct, vol.24, issue.5, pp.347-52, 2018.
DOI : 10.1097/mcc.0000000000000535

S. Gibot and P. Bollaert, Diagnostic non bactériologique des pneumopathies acquises sous ventilation mécanique, Réanimation. juin, vol.14, issue.4, pp.238-282, 2005.

C. M. Luna, D. Blanzaco, M. S. Niederman, W. Matarucco, N. C. Baredes et al., Resolution of ventilator-associated pneumonia: Prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome*, Crit Care Med. mars, vol.31, issue.3, pp.676-82, 2003.

, Recommandations nationales -Prévention de la transmission croisée : précautions complémentaires contact - Consensus formalisé d'experts - 2009, p.60

. Hcsp2013 and . Pdf,

E. Weiss, J. Zahar, P. Lesprit, E. Ruppe, M. Leone et al., Elaboration of a consensual definition of de-escalation allowing a ranking of ?-lactams, Clin Microbiol Infect. juill, vol.21, issue.7, pp.649-650, 2015.

X. Robin, N. Turck, A. Hainard, N. Tiberti, F. Lisacek et al., pROC: an open-source package for R and S+ to analyze and compare ROC curves, BMC Bioinformatics, vol.12, issue.1, p.77, 2011.
DOI : 10.1186/1471-2105-12-77

URL : https://bmcbioinformatics.biomedcentral.com/track/pdf/10.1186/1471-2105-12-77

, Automated methods, Model assessment, Bootstrapping, Forced entry, SAS macros, Framingham cohort, Int J Stat Appl, p.11, 2017.

J. Labarère, R. Bertrand, and M. J. Fine, How to derive and validate clinical prediction models for use in intensive care medicine, Intensive Care Med. avr, vol.40, issue.4, pp.513-540, 2014.

A. Kumar, N. Safdar, S. Kethireddy, and D. Chateau, A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: A metaanalytic/meta-regression study, Crit Care Med. août, vol.38, issue.8, pp.1651-64, 2010.

A. Vasudevan, A. Mukhopadhyay, J. Li, E. Yuen, and P. A. Tambyah, A prediction tool for nosocomial multi-drug resistant gram-negative bacilli infections in critically ill patients -prospective observational study, BMC Infect Dis, vol.14, issue.1
DOI : 10.1186/s12879-014-0615-z

URL : https://bmcinfectdis.biomedcentral.com/track/pdf/10.1186/s12879-014-0615-z

R. Sonti, M. E. Conroy, E. M. Welt, Y. Hu, G. Luta et al., Modeling risk for developing drug resistant bacterial infections in an MDR-naive critically ill population, Ther Adv Infect Dis. juill, vol.4, issue.4, pp.95-103, 2017.
DOI : 10.1177/2049936117715403

URL : http://europepmc.org/articles/pmc5507394?pdf=render

I. Chen, C. Lee, S. Ting, and W. Ly-c, Prediction of imipenem-resistant microorganisms among the nosocomial critically ill patients with Gram-negative bacilli septicemia: a simple risk score, Infect Drug Resist. mars, vol.11, pp.283-93, 2018.

S. Blot, P. Depuydt, and D. Vogelaers, Maximizing rates of empiric appropriate antibiotic therapy with minimized use of broad-spectrum agents: are surveillance cultures the key?, Intensive Care Med. déc, vol.34, issue.12, pp.2130-2133, 2008.

D. Vodovar, G. Marcadé, H. Rousseau, L. Raskine, E. Vicaut et al., Predictive factors for extendedspectrum beta-lactamase producing Enterobacteriaceae causing infection among intensive care unit patients with prior colonization, Infection. août, vol.42, issue.4, pp.743-751, 2014.

S. Patolia, G. Abate, N. Patel, S. Patolia, and S. Frey, Risk factors and outcomes for multidrug-resistant Gramnegative bacilli bacteremia, Ther Adv Infect Dis. janv, vol.5, issue.1, pp.11-19, 2018.
DOI : 10.1177/2049936117727497

URL : http://europepmc.org/articles/pmc5761922?pdf=render

, Surveillance des bactéries multirésistantes dans les établissements de santé en France. : 106

D. Sur,

A. Lefébure, E. Papy, C. Rioux, S. Diamantis, L. Armand-lefèvre et al., Audit of carbapenem prescriptions comparing 2 assessment periods, Médecine Mal Infect. juill, vol.45, issue.7, pp.273-281, 2015.

N. Brusselaers, S. Labeau, D. Vogelaers, and S. Blot, Value of lower respiratory tract surveillance cultures to predict bacterial pathogens in ventilator-associated pneumonia: systematic review and diagnostic test accuracy meta-analysis, Intensive Care Med. mars, vol.39, issue.3, pp.365-75, 2013.

H. Carbonne, L. Dorze, M. Bourrel, A. Poupet, H. Poyart et al., Relation between presence of extended-spectrum ?-lactamase-producing Enterobacteriaceae in systematic rectal swabs and respiratory tract specimens in ICU patients. Ann Intensive Care, vol.7, 2017.

W. Jalalzaï, M. Boutrot, J. Guinard, A. Guigon, L. Bret et al., Cessation of screening for intestinal carriage of extended-spectrum ?-lactamase-producing Enterobacteriaceae in a low-endemicity intensive care unit with universal contact precautions, Clin Microbiol Infect. avr, vol.24, issue.4, pp.429-436, 2018.

M. Detsis, S. Karanika, and E. Mylonakis, ICU Acquisition Rate, Risk Factors, and Clinical Significance of Digestive Tract Colonization With Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae: A Systematic Review and Meta-Analysis*, Crit Care Med. avr, vol.45, issue.4, pp.705-719, 2017.

M. Muhammed, M. E. Flokas, M. Detsis, M. Alevizakos, and E. Mylonakis, Comparison Between Carbapenems and ?-Lactam/?-Lactamase Inhibitors in the Treatment for Bloodstream Infections Caused by ExtendedSpectrum ?-Lactamase-Producing Enterobacteriaceae: A Systematic Review and Meta-Analysis. Open Forum Infect Dis, vol.4, 2017.

L. Cheng, B. C. Nelson, M. Mehta, N. Seval, S. Park et al., Piperacillin-Tazobactam versus Other Antibacterial Agents for Treatment of Bloodstream Infections Due to AmpC ?-Lactamase-Producing Enterobacteriaceae, Antimicrob Agents Chemother, issue.6, p.61

P. D. Tamma and J. Rodriguez-ba?o, The Use of Noncarbapenem ?-Lactams for the Treatment of ExtendedSpectrum ?-Lactamase Infections, Clin Infect Dis Off Publ Infect Dis Soc Am. 1 avr, vol.64, issue.7, pp.972-80, 2017.

A. M. Gibble, A. E. Gross, and A. M. Huang, Examining the Clinical Effectiveness of Non-Carbapenem ?-Lactams for the Treatment of Extended-Spectrum ?-Lactamase-Producing Enterobacteriaceae, Antibiotics. 15 déc, vol.4, issue.4, pp.653-66, 2015.

H. M. Nguyen, K. L. Shier, and C. J. Graber, Determining a clinical framework for use of cefepime and -lactam/ lactamase inhibitors in the treatment of infections caused by extended-spectrum--lactamase-producing Enterobacteriaceae, J Antimicrob Chemother. 1 avr, vol.69, issue.4, pp.871-80, 2014.

M. Sfeir, G. Askin, and C. P. , Beta-lactam/ beta-lactamase inhibitors versus carbapenem for bloodstream infections due to extended spectrum beta-lactamase producing Enterobacteriaceae : Systematic review and meta-analysis, Int J Antimicrob Agents

D. Sur,